BRPI1011815A2 - "composição farmacêutica para a contracepção de emergência" - Google Patents

"composição farmacêutica para a contracepção de emergência"

Info

Publication number: BRPI1011815A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; emergency contraception; contraception; emergency; pharmaceutical
Prior art date: 2009-06-23

Application number

BRPI1011815A

Other languages

English (en)

Inventor

Bernhard Lindenthal

Rolf Schürmann

Sascha General

Original Assignee

Bayer Pharma AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-23

Filing date

2010-06-10

Publication date

2016-03-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830690&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1011815(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-06-10 Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG

2016-03-29 Publication of BRPI1011815A2 publication Critical patent/BRPI1011815A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

BRPI1011815A 2009-06-23 2010-06-10 "composição farmacêutica para a contracepção de emergência" BRPI1011815A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102009030607		2009-06-23
PCT/EP2010/003497 WO2010149273A1 (de)	2009-06-23	2010-06-10	Pharmazeutische zusammensetzung zur notfallempfängnisverhütung

Publications (1)

Publication Number	Publication Date
BRPI1011815A2 true BRPI1011815A2 (pt)	2016-03-29

Family

ID=42830690

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1011815A BRPI1011815A2 (pt)	2009-06-23	2010-06-10	"composição farmacêutica para a contracepção de emergência"

Country Status (29)

Country	Link
US (2)	US8921345B2 (pt)
EP (2)	EP2445491B1 (pt)
JP (2)	JP5801801B2 (pt)
KR (1)	KR20120044307A (pt)
CN (1)	CN102458386B (pt)
AR (1)	AR077199A1 (pt)
AU (1)	AU2010265180B2 (pt)
BR (1)	BRPI1011815A2 (pt)
CA (1)	CA2766197C (pt)
CL (1)	CL2011003291A1 (pt)
CO (1)	CO6480948A2 (pt)
CR (1)	CR20110699A (pt)
CU (1)	CU20110239A7 (pt)
DO (1)	DOP2011000402A (pt)
EA (1)	EA023780B1 (pt)
EC (1)	ECSP11011546A (pt)
ES (1)	ES2625950T3 (pt)
IL (2)	IL216668A (pt)
MA (1)	MA33373B1 (pt)
MX (1)	MX2011013959A (pt)
MY (1)	MY158476A (pt)
NZ (1)	NZ597239A (pt)
PE (1)	PE20120860A1 (pt)
SG (1)	SG177284A1 (pt)
TN (1)	TN2011000656A1 (pt)
TW (1)	TWI466673B (pt)
UA (1)	UA108741C2 (pt)
UY (1)	UY32728A (pt)
WO (1)	WO2010149273A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101890025A (zh) *	2009-05-20	2010-11-24	北京紫竹药业有限公司	孕二烯酮在制备紧急避孕药物中的应用
JP5801801B2 (ja)	2009-06-23	2015-10-28	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	緊急避妊のための医薬組成物及び処置方法
EP2383279A1 (en)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Process for the preparation of estetrol
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
EP3936133A1 (en)	2011-11-23	2022-01-12	TherapeuticsMD, Inc.	Natural combination hormone replacement formulations and therapies
FR2987271B1 (fr) *	2012-02-28	2017-08-18	Hra Pharma Lab	Combinaison de modulateurs selectifs du recepteur a la progesterone et d'anti-inflammatoires non steroidiens
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
EP2730284A1 (en) *	2012-11-12	2014-05-14	Naari AG	Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation
HK1207588A1 (en) *	2012-11-22	2016-02-05	Bayer Pharma Aktiengesellschaft	Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014187744A1 (de)	2013-05-23	2014-11-27	Bayer Pharma Aktiengesellschaft	Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen („on-demand") kontrazeption
US10206932B2 (en)	2014-05-22	2019-02-19	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
KR101650778B1 (ko)	2014-10-17	2016-08-25	충북대학교 산학협력단	폴로유사인산화효소-1의 폴로박스 도메인에 특이적으로 결합하는 펩타이드 유사체 및 이를 유효성분으로 포함하는 피임용 조성물
PL3106148T3 (pl)	2015-06-18	2018-08-31	Mithra Pharmaceuticals S A	Jednostka dawkowania ulegająca rozpadowi w jamie ustnej zawierająca składnik estetrolowy
CN107810001A (zh)	2015-06-18	2018-03-16	密特拉制药公司	含雌四醇的口腔分散片剂
CN107787224A (zh)	2015-06-18	2018-03-09	密特拉制药公司	含雌四醇组分的口腔分散剂量单位
CA2988362C (en)	2015-06-18	2022-07-19	Mithra Pharmaceuticals S.A.	Orodispersible tablet containing estetrol
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
CA3020153A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
CA3178291A1 (en)	2016-08-05	2018-04-12	Estetra Srl	Method for the management of dysmenorrhea and menstrual pain
CN107383353A (zh) *	2017-08-31	2017-11-24	浙江道明光电科技有限公司	一种硅烷改性聚酯预聚物的制备方法
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar)	2018-04-19	2019-10-19	Estetra Sprl	مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
US11376263B2 (en) *	2020-10-08	2022-07-05	Fortress Biotech, Inc.	Cyproterone acetate compositions and uses thereof
WO2022225986A1 (en) *	2021-04-19	2022-10-27	Archer David Fitzgerald	On demand female contraceptive
US11679114B2 (en)	2021-07-26	2023-06-20	Navad Life Sciences Pte	Progestogen-only oral contraception

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997031631A1 (en)	1996-02-27	1997-09-04	Rpms Technology Limited	Cox-2 selective inhibitors for managing labour and uterine contractions
US6197327B1 (en)	1997-06-11	2001-03-06	Umd, Inc.	Device and method for treatment of dysmenorrhea
WO2002062391A2 (en) *	2001-02-02	2002-08-15	Pharmacia Corporation	Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea
HU227198B1 (en)	2001-11-27	2010-10-28	Richter Gedeon Nyrt	Pharmaceutical composition for emergency contraception containing levonorgestrel
US20040058975A1 (en) *	2002-06-26	2004-03-25	Schering Ag	Method for fertility control
JP5801801B2 (ja)	2009-06-23	2015-10-28	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	緊急避妊のための医薬組成物及び処置方法
HK1207588A1 (en)	2012-11-22	2016-02-05	Bayer Pharma Aktiengesellschaft	Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception

2010
- 2010-06-10 JP JP2012516546A patent/JP5801801B2/ja not_active Expired - Fee Related
- 2010-06-10 KR KR20117030683A patent/KR20120044307A/ko not_active Abandoned
- 2010-06-10 NZ NZ597239A patent/NZ597239A/xx not_active IP Right Cessation
- 2010-06-10 UA UAA201200491A patent/UA108741C2/uk unknown
- 2010-06-10 PE PE2011002145A patent/PE20120860A1/es not_active Application Discontinuation
- 2010-06-10 CA CA2766197A patent/CA2766197C/en not_active Expired - Fee Related
- 2010-06-10 EA EA201200029A patent/EA023780B1/ru not_active IP Right Cessation
- 2010-06-10 US US13/377,809 patent/US8921345B2/en not_active Expired - Fee Related
- 2010-06-10 WO PCT/EP2010/003497 patent/WO2010149273A1/de not_active Ceased
- 2010-06-10 SG SG2011093986A patent/SG177284A1/en unknown
- 2010-06-10 EP EP10722968.4A patent/EP2445491B1/de not_active Not-in-force
- 2010-06-10 CN CN201080028041.1A patent/CN102458386B/zh not_active Expired - Fee Related
- 2010-06-10 MX MX2011013959A patent/MX2011013959A/es active IP Right Grant
- 2010-06-10 MA MA34470A patent/MA33373B1/fr unknown
- 2010-06-10 EP EP16206219.4A patent/EP3178476A1/de not_active Withdrawn
- 2010-06-10 BR BRPI1011815A patent/BRPI1011815A2/pt not_active IP Right Cessation
- 2010-06-10 MY MYPI2011006162A patent/MY158476A/en unknown
- 2010-06-10 AU AU2010265180A patent/AU2010265180B2/en not_active Ceased
- 2010-06-10 ES ES10722968.4T patent/ES2625950T3/es active Active
- 2010-06-23 UY UY32728A patent/UY32728A/es not_active Application Discontinuation
- 2010-06-23 AR ARP100102209 patent/AR077199A1/es unknown
- 2010-06-23 TW TW99120494A patent/TWI466673B/zh not_active IP Right Cessation
2011
- 2011-11-29 IL IL216668A patent/IL216668A/en not_active IP Right Cessation
- 2011-12-21 CR CR20110699A patent/CR20110699A/es unknown
- 2011-12-22 CU CU20110239A patent/CU20110239A7/es unknown
- 2011-12-22 TN TNP2011000656A patent/TN2011000656A1/en unknown
- 2011-12-22 EC ECSP11011546 patent/ECSP11011546A/es unknown
- 2011-12-23 CL CL2011003291A patent/CL2011003291A1/es unknown
- 2011-12-23 DO DO2011000402A patent/DOP2011000402A/es unknown
- 2011-12-23 CO CO11177791A patent/CO6480948A2/es active IP Right Grant
2014
- 2014-12-12 US US14/569,579 patent/US9907806B2/en not_active Expired - Fee Related
2015
- 2015-06-10 JP JP2015117508A patent/JP2015163646A/ja active Pending
2016
- 2016-02-25 IL IL244293A patent/IL244293A0/en unknown

Also Published As

Publication number	Publication date
MY158476A (en)	2016-10-14
AU2010265180A1 (en)	2012-01-19
US20120172343A1 (en)	2012-07-05
ES2625950T3 (es)	2017-07-21
HK1170686A1 (zh)	2013-03-08
IL216668A0 (en)	2012-02-29
EP2445491B1 (de)	2017-03-08
IL244293A0 (en)	2016-04-21
AR077199A1 (es)	2011-08-10
US9907806B2 (en)	2018-03-06
US8921345B2 (en)	2014-12-30
KR20120044307A (ko)	2012-05-07
NZ597239A (en)	2013-07-26
UA108741C2 (uk)	2015-06-10
UY32728A (es)	2011-01-31
EA201200029A1 (ru)	2012-07-30
TN2011000656A1 (en)	2013-05-24
CU20110239A7 (es)	2012-04-15
CL2011003291A1 (es)	2012-07-27
ECSP11011546A (es)	2012-01-31
DOP2011000402A (es)	2012-01-15
PE20120860A1 (es)	2012-07-15
WO2010149273A1 (de)	2010-12-29
CR20110699A (es)	2012-03-12
JP2012530733A (ja)	2012-12-06
MX2011013959A (es)	2012-01-25
SG177284A1 (en)	2012-02-28
CA2766197A1 (en)	2010-12-29
EA023780B1 (ru)	2016-07-29
EP2445491A1 (de)	2012-05-02
EP3178476A1 (de)	2017-06-14
IL216668A (en)	2016-03-31
JP2015163646A (ja)	2015-09-10
JP5801801B2 (ja)	2015-10-28
AU2010265180B2 (en)	2014-09-11
CA2766197C (en)	2017-07-25
MA33373B1 (fr)	2012-06-01
US20150105359A1 (en)	2015-04-16
TW201105330A (en)	2011-02-16
TWI466673B (zh)	2015-01-01
CO6480948A2 (es)	2012-07-16
CN102458386B (zh)	2016-04-06
CN102458386A (zh)	2012-05-16

Publication	Publication Date	Title
BRPI1011815A2 (pt)	2016-03-29	"composição farmacêutica para a contracepção de emergência"
HUS2200018I1 (hu)	2022-06-28	Drospirenont tartalmazó gyógyszerkészítmény, fogamzásgátlóként történõ alkalmazásra
BRPI0919466A2 (pt)	2015-12-01	composição farmacêutica para liberação modificada
FR2959935B1 (fr)	2013-02-08	Forme pharmaceutique orale alcoolo-resistante
HUE037520T2 (hu)	2018-09-28	Méhen belüli adagoló eszköz fogamzásgátlás céljára
BRPI0814157A2 (pt)	2015-01-06	Composição de catalisador e processos para a preparação e uma composição de catalisador e para desalquilação de etil-benzeno
BRPI1008598A2 (pt)	2016-03-15	composição farmacêutica para inalação
BRPI0918971A2 (pt)	2015-12-01	tienopirimidinas para composições farmacêuticas
PT2435030E (pt)	2015-02-27	Composições farmacêuticas flutuantes de libertação controlada
EP2453877A4 (en)	2013-05-29	MEDICAMENT COMPOSITION WITH DELAYED RELEASE
BRPI1012004A2 (pt)	2016-05-10	"forma farmacêutica"
BRPI0810139A2 (pt)	2014-10-29	Catalisador para a preparação de metil mercaptano
BRPI1011412A2 (pt)	2016-03-15	composição para liberação sustentada de droga compreendendo alutinante geopolimérico
BR112012001050A2 (pt)	2016-03-15	agente de ligação para a produção de marcações de estrada rapidamente pronta para tráfego
BRPI1007484A2 (pt)	2016-02-16	composição farmacêutica para administração oral
BRPI0809288A2 (pt)	2014-10-14	Formulações farmacêuticas auto-precipitação para a liberação modificada de um princípio ativo
EP2465512A4 (en)	2013-02-20	PAIN-SUBJECTIVE PHARMACEUTICAL COMPOSITION
BR112012004215A2 (pt)	2019-09-24	"dispositivo para dispensação de um material dental"
BRPI1013037A2 (pt)	2019-09-24	"solução farmacêutica oral de telmisartan"
BRPI0819571A2 (pt)	2019-09-24	"método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
BRPI0919194A2 (pt)	2015-12-15	preparação sólida para administração oral
PT2139505E (pt)	2014-09-17	Nova composição farmacêutica para utilização como laxativo
BR112012004862A2 (pt)	2015-09-08	método para a preparação de um composto , duloxetina cristalina, e, composição farmacêutica
BRPI0906045A2 (pt)	2015-07-07	"composição farmacêutica para administração nasal"
EP2520300A4 (en)	2013-05-08	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION

Legal Events

Date	Code	Title	Description
2016-11-01	B25A	Requested transfer of rights approved	Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-10	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 8A ANUIDADE.
2018-07-31	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-08-07	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]